Pharma Bio Services (PBSV) Price & Analysis

Q: What was Pharma Bio Serv Inc’s price range in the past 12 months?

Pharma Bio Serv Inc lowest stock price was $0.31 and its highest was $1.36 in the past 12 months.

Q: What is Pharma Bio Serv Inc’s market cap?

Pharma Bio Serv Inc’s market cap is $14.32M.

Q: When is Pharma Bio Serv Inc’s upcoming earnings report date?

Pharma Bio Serv Inc’s upcoming earnings report date is Feb 04, 2026 which is in 109 days.

Q: How were Pharma Bio Serv Inc’s earnings last quarter?

Pharma Bio Serv Inc released its earnings results on Sep 10, 2025. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.

Q: Is Pharma Bio Serv Inc overvalued?

According to Wall Street analysts Pharma Bio Serv Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Pharma Bio Serv Inc pay dividends?

Pharma Bio Serv Inc pays a Notavailable dividend of $0.075 which represents an annual dividend yield of N/A. See more information on Pharma Bio Serv Inc dividends here

Q: What is Pharma Bio Serv Inc’s EPS estimate?

Pharma Bio Serv Inc’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Pharma Bio Serv Inc have?

Pharma Bio Serv Inc has 22,918,093 shares outstanding.

Q: What happened to Pharma Bio Serv Inc’s price movement after its last earnings report?

Pharma Bio Serv Inc reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went down -3.226%.

Q: Which hedge fund is a major shareholder of Pharma Bio Serv Inc?

Currently, no hedge funds are holding shares in PBSV

Compare

44 Followers

PBSV Stock Chart & Stats

$0.62

-$0.14(-25.27%)

At close: Jan 07 4:00 PM EST

$0.62

-$0.14(-25.27%)

Day’s Range― - ―

52-Week Range$0.31 - $1.36

Previous CloseN/A

Volume2.02K

Average Volume (3M)7.95K

Market Cap

$14.32M

Enterprise Value$3.34M

Total Cash (Recent Filing)$10.73B

Total Debt (Recent Filing)$71.36M

Price to Earnings (P/E)―

Beta-0.13

Next Earnings

Feb 04, 2026

EPS EstimateN/A

Last Dividend Ex-Date

Feb 28, 2025

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding22,918,093

10 Day Avg. Volume1,280

30 Day Avg. Volume7,946

Financial Highlights & Ratios

PEG Ratio0.11

Price to Book (P/B)0.97

Price to Sales (P/S)1.40

P/FCF Ratio-18.34

Enterprise Value/Market Cap0.23

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda-9.90

Forecast

1Y Price Target

$0.50

Price Target Upside-19.35% Downside

Rating ConsensusHold

Number of Analyst Covering1

Pharma Bio Services News

Is PBSV a Buy, Before Earnings?

Pharma Bio Serv Inc (PBSV) is scheduled to report 3rd quarter earnings on 09/10/2025. Regarding Q3 estimates, Wall...

1M ago

PBSV

PBSV Earnings this Week: How Will it Perform?

Pharma Bio Serv Inc (PBSV) is scheduled to report 2nd quarter earnings on 06/11/2025. Regarding Q2 estimates, Wall...

4M ago

PBSV

Pharma Bio Services Elects New Director at Annual Meeting

Pharma Bio Services ( ($PBSV) ) has issued an announcement. On May 15, 2025, Pharma-Bio Serv, Inc. held...

5M ago

PBSV

PBSV Upcoming Earnings Report: What to Expect?

Pharma Bio Serv Inc (PBSV) is scheduled to report 3rd quarter earnings on 09/12/2024. Regarding Q3 estimates, Wall...

1y ago

PBSV

Pharma Bio Services: Incentive Plan Extended, Directors Elected

Pharma Bio Services (PBSV) has issued an update. At Pharma-Bio Serv, Inc.’s 2024 Annual Meeting, stockholders approved an...

1y ago

PBSV

PBSV Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pharma Bio Serv Inc (PBSV) is scheduled to report 1st quarter earnings on 03/18/2024. Regarding Q1 estimates, Wall...

2y ago

PBSV

PBSV Upcoming Earnings Report: What to Expect?

Pharma Bio Serv Inc (PBSV) is scheduled to report 4th quarter earnings on 01/29/2024. Regarding Q4 estimates, Wall...

2y ago

PBSV

PBSV Upcoming Earnings Report: What to Expect?

Pharma Bio Serv Inc (PBSV) is scheduled to report 3rd quarter earnings on 09/14/2023. Regarding Q3 estimates, Wall...

2y ago

PBSV

PBSV FAQ

What was Pharma Bio Serv Inc’s price range in the past 12 months?

Pharma Bio Serv Inc lowest stock price was $0.31 and its highest was $1.36 in the past 12 months.

What is Pharma Bio Serv Inc’s market cap?

Pharma Bio Serv Inc’s market cap is $14.32M.

When is Pharma Bio Serv Inc’s upcoming earnings report date?

Pharma Bio Serv Inc’s upcoming earnings report date is Feb 04, 2026 which is in 109 days.

How were Pharma Bio Serv Inc’s earnings last quarter?

Pharma Bio Serv Inc released its earnings results on Sep 10, 2025. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.

Is Pharma Bio Serv Inc overvalued?

According to Wall Street analysts Pharma Bio Serv Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Pharma Bio Serv Inc pay dividends?

Pharma Bio Serv Inc pays a Notavailable dividend of $0.075 which represents an annual dividend yield of N/A. See more information on Pharma Bio Serv Inc dividends here

What is Pharma Bio Serv Inc’s EPS estimate?

Pharma Bio Serv Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pharma Bio Serv Inc have?

Pharma Bio Serv Inc has 22,918,093 shares outstanding.

What happened to Pharma Bio Serv Inc’s price movement after its last earnings report?

Pharma Bio Serv Inc reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went down -3.226%.

Which hedge fund is a major shareholder of Pharma Bio Serv Inc?

Currently, no hedge funds are holding shares in PBSV

Company Description

Pharma Bio Serv Inc

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Pharma Bio Services (PBSV) Earnings & Revenues

Historic Earnings Reports

PBSV Stock 12 Month Forecast

Average Price Target

$0.50

▼(-19.35% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.6,0.5923076923076923,0.5846153846153846,0.5769230769230769,0.5692307692307692,0.5615384615384615,0.5538461538461539,0.5461538461538461,0.5384615384615384,0.5307692307692308,0.5230769230769231,0.5153846153846153,0.5076923076923077,{"y":0.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.6,0.5923076923076923,0.5846153846153846,0.5769230769230769,0.5692307692307692,0.5615384615384615,0.5538461538461539,0.5461538461538461,0.5384615384615384,0.5307692307692308,0.5230769230769231,0.5153846153846153,0.5076923076923077,{"y":0.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.6,0.5923076923076923,0.5846153846153846,0.5769230769230769,0.5692307692307692,0.5615384615384615,0.5538461538461539,0.5461538461538461,0.5384615384615384,0.5307692307692308,0.5230769230769231,0.5153846153846153,0.5076923076923077,{"y":0.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.53,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.51,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.5,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.5,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.48,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.52,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.56,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.5,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.45,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.5,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.51,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >